Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-19.31	90.71	-112.43
Graham Fair Price	-40.25	3.40	5.70
PEG	5649.37	-0.38	< 0.005
Price/Book	-0.42	0.77	0.77
Price/Cash Flow	-58.82	-91.43	222.04
Prices/Earnings	-181.29	-24.99	-8.88
Price/Sales	13.13	12.39	10.95
Price/FCF	-58.82	-91.43	222.04
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	100.08	0.33	0.16
Operating Margin	70.03	-0.10	-0.35
ROA	64.10	< 0.005	-0.02
ROE	-0.02	< 0.005	64.60
ROIC	-0.01	< 0.005	65.15
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	-0.05	49.11
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-5.39	0.74	-86.37
EPS QOQ	-13.29	0.65	-95.11
FCF QOQ	-0.81	-3.43	-322.86
Revenue QOQ	-0.02	-0.12	-425.33
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	7.59	12.69	67.26
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	11.86	7.09	-40.21
Debt/Capitalization	0.24	0.24	-2.37
Quick Ratio	1.23	1.06	-13.48
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	8.14	8.17	0.43
Cash	1.77	1.81	2.55
Capex	0.00	0.00	0.00
Free Cash Flow	0.03	-0.07	142.86
Revenue	0.58	0.51	-11.60
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.79	1.45	-19.21
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-13.30	9.43	-29.16
Naive Interpretation	Member

06 - Financial Health · Weak

Rating